935471-87-7Relevant academic research and scientific papers
An efficient lactamization of fimbrolides to novel 1,5-dihydropyrrol-2-ones
Goh, Wai Kean,Iskander, George,Black, David StC,Kumar, Naresh
, p. 2287 - 2290 (2007)
A new versatile method for the conversion of fimbrolides to the corresponding novel dihydropyrrol-2-ones is described. This new efficient lactamization protocol has the advantage of higher yields and can be used for the synthesis of a series of new dihydr
Synthesis, quorum sensing inhibition and docking studies of 1,5-dihydropyrrol-2-ones
Goh, Wai-Kean,Gardner, Christopher R.,Chandra Sekhar, Kondapalli V.G.,Biswas, Nripendra N.,Nizalapur, Shashidhar,Rice, Scott A.,Willcox, Mark,Black, David Stc.,Kumar, Naresh
, p. 7366 - 7377 (2015/11/27)
Gram-negative bacteria such as Pseudomonas aeruginosa and Escherichia coli use N-acylated l-homoserine lactones (AHLs) as autoinducers (AIs) for quorum sensing (QS), a chief regulatory and cell-to-cell communication system. QS is responsible for social adaptation, virulence factor production, biofilm production and antibiotic resistance in bacteria. Fimbrolides, a class of halogenated furanones isolated from the red marine alga Delisea pulchra, have been shown to exhibit promising QS inhibitory activity against various Gram-negative and Gram-positive bacterial strains. In this work, various lactam analogues of fimbrolides viz., 1,5-dihydropyrrol-2-ones, were designed and synthesized via an efficient lactamization protocol. All the synthesized analogues were tested for QS inhibition against the E. coli AHL-monitor strain JB357 gfp (ASV). Compound 17a emerged as the most potent compound, followed by 9c, with AIC40 values (the ratio of synthetic inhibitor to natural AHL signaling molecule that is required to lower GFP expression to 40%) of 1.95 and 19.00, respectively. Finally, the potential binding interactions between the synthesized molecules and the LasR QS receptor were studied by molecular docking. Our results indicate that 1,5-dihydropyrrol-2-ones have the ability to serve as potential leads for the further development of novel QS inhibitors as antimicrobial therapeutics.
